Similar to one of the mechanisms in endothelial cells, activation of PPARδ has been shown to promote the binding of inflammatory suppressor BCL-6 to the promoter of group IIA secretory phospholipase A2, an inflammatory marker for atherosclerosis, and therefore inhibit the inflammation induced by IL-1b in VSMCs [25]. This evidence concerns the gene IL1B and atherosclerosis.